Dai-Dan Co., Ltd. (TYO:1980)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	245,436	159,108	106,745	50,720	44,904	63,329
Market Cap Growth	44.90%	49.05%	110.46%	12.95%	-29.09%	0.58%
Enterprise Value	205,478	157,401	96,949	36,948	31,820	40,089
Last Close Price	5720.00	3710.00	2378.35	1089.12	923.27	1255.83
PE Ratio	10.66	9.12	11.75	7.66	7.77	10.02
PS Ratio	0.88	0.61	0.54	0.27	0.28	0.40
PB Ratio	2.22	1.46	1.14	0.62	0.58	0.85
P/TBV Ratio	2.38	1.57	1.16	0.63	0.59	0.85
P/FCF Ratio	-	13.19	-	3.59	-	4.56
P/OCF Ratio	-	12.83	179.10	3.18	-	4.45
EV/Sales Ratio	0.74	0.60	0.49	0.20	0.20	0.25
EV/EBITDA Ratio	6.37	6.52	8.33	4.14	3.96	4.34
EV/EBIT Ratio	6.61	6.83	8.91	4.38	4.20	4.58
EV/FCF Ratio	-	13.05	-	2.61	-	2.89
Debt / Equity Ratio	0.03	0.22	0.03	0.04	0.05	0.07
Debt / EBITDA Ratio	0.11	0.98	0.27	0.41	0.49	0.56
Debt / FCF Ratio	-	1.96	-	0.26	-	0.37
Asset Turnover	1.60	1.40	1.28	1.29	1.20	1.24
Inventory Turnover	145.76	273.65	245.12	287.82	339.39	328.57
Quick Ratio	1.85	1.53	1.79	1.70	1.74	1.80
Current Ratio	2.06	1.65	1.84	1.76	1.82	1.83
Return on Equity (ROE)	22.65%	17.23%	10.34%	8.30%	7.55%	8.88%
Return on Assets (ROA)	11.11%	7.66%	4.40%	3.67%	3.50%	4.29%
Return on Capital (ROIC)	16.79%	12.52%	7.42%	6.30%	5.88%	7.15%
Return on Capital Employed (ROCE)	26.30%	20.10%	10.90%	9.70%	9.30%	11.00%
Earnings Yield	9.38%	10.96%	8.51%	13.06%	12.87%	9.98%
FCF Yield	-	7.58%	-0.96%	27.87%	-28.67%	21.91%
Dividend Yield	2.90%	4.39%	3.17%	4.13%	4.87%	3.58%
Payout Ratio	-	24.65%	26.02%	29.20%	33.49%	32.80%
Buyback Yield / Dilution	-0.08%	-0.08%	-0.08%	-0.08%	1.17%	1.48%
Total Shareholder Return	2.81%	4.31%	3.10%	4.05%	6.05%	5.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.